Advanced search
Publication Cover
Drug Design, Development and Therapy Volume 11, 2017 - Issue
Submit an article Journal homepage
202
Views
11
CrossRef citations to date
0
Altmetric
Original Research

Failure mode and effects analysis drastically reduced potential risks in clinical trial conduct

Howard Lee1 Department of Clinical Pharmacology and Therapeutics, Seoul National University College of Medicine and Hospital;2 Department of Transdisciplinary Studies, Graduate School of Convergence Science and Technology, Seoul National UniversityCorrespondence[email protected]
,
Heechan Lee1 Department of Clinical Pharmacology and Therapeutics, Seoul National University College of Medicine and Hospital;2 Department of Transdisciplinary Studies, Graduate School of Convergence Science and Technology, Seoul National University
,
Jungmi Baik3 Clinical Trials Center, Seoul National University Hospital, Seoul, Republic of Korea
,
Hyunjung Kim3 Clinical Trials Center, Seoul National University Hospital, Seoul, Republic of Korea
&
Rachel Kim4 Global Clinical Trial Execution, Pfizer Korea, Seoul, Republic of Korea
Pages 3035-3043 | Published online: 19 Oct 2017

References

  • BhattAQuality of clinical trials: a moving targetPerspect Clin Res201124 124 12822145122
  • MacriMManaging clinical trial risk: it’s a tough job, but one person has to do itinVentiv Health Clinical2014 1 4
  • European Medicines AgencyReflection paper on risk based quality management in clinical trials2013 Available from: http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2013/11/WC500155491.pdfAccessed September 11, 2017
  • US Food and Drug Administration, Center for Drug Evaluation and Research (CDER), Center for Biologics Evaluation and Research (CBER)Guidance for Industry. Oversight of Clinical Investigations – A Risk-Based Approach to Monitoring2013 Available from: https://www.fda.gov/downloads/Drugs/Guidances/UCM269919.pdfAccessed September 11, 2017
  • US Food and Drug AdministrationClinical Investigators – Disquali-fication Proceedings Available from: http://www.accessdata.fda.gov/scripts/SDA/sdNavigation.cfm?sd=clinicalinvestigatorsdisqualificationproceedingsAccessed 26 Dec 2016
  • US Food and Drug Administration, Center for Drug Evaluation and Research (CDER), Center for Biologics Evaluation and Research (CBER)Guidance for Industry. Q9 Quality Risk Management2006 Available from: https://www.fda.gov/downloads/Drugs/Guidances/ucm073511.pdfAccessed September 11, 2017
  • LiuHCLiuLLiuNRisk evaluation approaches in failure mode and effects analysis: a literature reviewExpert Syst Appl2013402 828 838
  • AsefzadehSYarmohammadianMHNikpeyAAtighechianGClinical risk assessment in intensive care unitInt J Prev Med201345 592 59823930171
  • ChiozzaMLPonzettiCFMEA: a model for reducing medical errorsClin Chim Acta20094041 75 7819298799
  • ScorsettiMSignoriCLattuadaPApplying failure mode effects and criticality analysis in radiotherapy: lessons learned and perspectives of enhancementRadiother Oncol2010943 367 37420116118
  • KuoFYHuangWCChiouKRThe effect of failure mode and effect analysis on reducing percutaneous coronary intervention hospital door-to-balloon time and mortality in ST segment elevation myocardial infarctionBMJ Qual Saf2013228 626 638
  • BonfantGBelfantiPPaternosterGClinical risk analysis with failure mode and effect analysis (FMEA) model in a dialysis unitJ Nephrol2010231 111 11820091494
  • HoverARSistrunkWWCavagnolRMEffectiveness and cost of failure mode and effects analysis methodology to reduce neurosurgical site infectionsAm J Med Qual2014296 517 52124101683
  • CodyRJAnticipating risk for human subjects participating in clinical research: application of failure mode and effects analysisCancer Invest2006242 209 21416537191
  • VeroneseIDe MartinEMartinottiASMulti-institutional application of failure mode and effects analysis (FMEA) to cyberKnife stereotactic body radiation therapy (SBRT)Radiat Oncol201510 13226071401
  • Rodriguez-GonzalezCGMartin-BarberoMLHerranz-AlonsoAUse of failure mode, effect and criticality analysis to improve safety in the medication administration processJ Eval Clin Pract2015214 549 55925847021
  • SaylerEEldredge-HindyHDinomeJLockamyVHarrisonASClinical implementation and failure mode and effects analysis of HDR skin brachytherapy using Valencia and Leipzig surface applicatorsBrachytherapy2015142 293 29925516493
  • MayadevJDieterichSHarseRA failure modes and effects analysis study for gynecologic high-dose-rate brachytherapyBrachytherapy2015146 866 87526204807
  • HaynesABWeiserTGBerryWRChanges in safety attitude and relationship to decreased postoperative morbidity and mortality following implementation of a checklist-based surgical safety interventionBMJ Qual Saf2011201 102 107
  • AshleyLArmitageGFailure mode and effects analysis: an empirical comparison of failure mode scoring proceduresJ Patient Saf201064 210 21521500607
  • WilkinsonDAKolarMDFailure modes and effects analysis applied to high-dose-rate brachytherapy treatment planningBrachytherapy2013124 382 38623664645
  • DeRosierJStalhandskeEBagianJPNudellTUsing health care failure mode and effect analysis: the VA national center for patient safety’s prospective risk analysis systemJt Comm J Qual Improv2002285 248 267 20912053459

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.